CD4+ T‐cell Transcription Factors in Idiopathic REM Sleep Behavior Disorder and Parkinson's Disease
Background CD4+ T‐cell dysregulation occurs in Parkinson's disease (PD); however, it is unknown whether it contributes to PD development. The objective of this study was to investigate transcription factor gene expression in CD4+ T cells in idiopathic rapid eye movement sleep behavior disorder,...
        Saved in:
      
    
          | Published in | Movement disorders Vol. 36; no. 1; pp. 225 - 229 | 
|---|---|
| Main Authors | , , , , , , , , , | 
| Format | Journal Article | 
| Language | English | 
| Published | 
        Hoboken, USA
          John Wiley & Sons, Inc
    
        01.01.2021
     Wiley Subscription Services, Inc  | 
| Subjects | |
| Online Access | Get full text | 
| ISSN | 0885-3185 1531-8257 1531-8257  | 
| DOI | 10.1002/mds.28137 | 
Cover
| Summary: | Background
CD4+ T‐cell dysregulation occurs in Parkinson's disease (PD); however, it is unknown whether it contributes to PD development. The objective of this study was to investigate transcription factor gene expression in CD4+ T cells in idiopathic rapid eye movement sleep behavior disorder, the strongest risk factor for prodromal PD.
Methods
Expression of transcription factors (TBX21, STAT1, STAT3, STAT4, STAT6, RORC, GATA3, FOXP3, and NR4A2) was measured in CD4+ T cells from 33 polysomnographically confirmed idiopathic rapid eye movement sleep behavior disorder subjects and compared with expression in cells from matched healthy subjects and antiparkinson drugs‐naive PD patients.
Results
Compared with healthy subjects, idiopathic rapid eye movement sleep behavior disorder subjects and PD patients had lower TBX21, STAT3, and STAT4, and higher FOXP3 expression. TBX21 expression discriminated healthy subjects from idiopathic rapid eye movement sleep behavior disorder subjects and PD patients, but not idiopathic rapid eye movement sleep behavior disorder subjects with PD.
Conclusions
In idiopathic rapid eye movement sleep behavior disorder subjects CD4+ T cells exhibit a peculiar molecular signature strongly resembling cells from PD patients, suggesting early involvement of peripheral immunity in PD. © 2020 International Parkinson and Movement Disorder Society | 
|---|---|
| Bibliography: | Nothing to report. Relevant conflicts of interest/financial disclosures Studies in healthy subjects and PD patients were supported by a grant from Fondazione CARIPLO to Marco Cosentino (Project 2011‐0504: Dopaminergic modulation of CD4+ T lymphocytes: relevance for neurodegeneration and neuroprotection in Parkinson's disease — The dopaminergic neuro‐immune connection). The study was supported in part by a contribution from the AGING Project, Department of Excellence, University of Piemonte Orientale, Novara, Italy. Funding agencies ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23  | 
| ISSN: | 0885-3185 1531-8257 1531-8257  | 
| DOI: | 10.1002/mds.28137 |